Global Respiratory Trainer Market: Restraint
Product recall and critical regulatory compliance procedures may act as a restraint for growth of the respiratory trainer market. For instance, in July 2021, the U.S. Food and Drug Administration (FDA) directed Philips Respironics, a medical devices company to recall millions of sleep and respiratory devices following concerns that foam in the devices, which is used to reduce sound and vibration, may break into particles and enter the air hose of the device and be inhaled by the user.
Moreover, in 2020, the U.S. FDA issued guidance to formulate a policy to help expand the availability of ventilators as well as other respiratory devices and their accessories during the COVID-19 pandemic.
Market Drivers
Product recall and critical regulatory compliance procedures may act as a restraint for growth of the respiratory trainer market. For instance, in July 2021, the U.S. Food and Drug Administration (FDA) directed Philips Respironics, a medical devices company to recall millions of sleep and respiratory devices following concerns that foam in the devices, which is used to reduce sound and vibration, may break into particles and enter the air hose of the device and be inhaled by the user.
Moreover, in 2020, the U.S. FDA issued guidance to formulate a policy to help expand the availability of ventilators as well as other respiratory devices and their accessories during the COVID-19 pandemic.
Restraints
Respiratory Trainer Market Report Snapshots
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients